Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Repligen Corp (RGEN) -- Ignore unavailable to you. Want to Upgrade?

To: LLCF who wrote (102)	3/10/1999 9:45:00 AM
From: scaram(o)uche	Read Replies (3) \| Respond to of 395

Cool.... I'll take a look. IMO, these guys are straight-shooters, honestly struggling to bring the company back and to apply good science to business. As I've mentioned before, I'm not enthusiastic about attempts to engineer the angiogenesis inhibitors that interact with heparan. I'd love to be wrong. I don't currently own any shares. But, I have met with "these guys" on at least four separate occasions, once doing business and three times as a private investor. I like them. I feel that they are rowing against a tough current, but..... they are my type of managers/scientists.